HCPCS Q0249 — Tocilizumab for covid-19 (2026 RVU Values)
HCPCS code Q0249 (Tocilizumab for covid-19) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.
HCPCS code Q0249 (Tocilizumab for covid-19) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.